Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.
- Published In:
- Proceedings of the National Academy of Sciences of the United States of America, 91(21), 9770-4 (1994)
- Authors:
- Wild, C T, Shugars, D C, Greenwell, T K, McDanal, C B, Matthews, T J
- Database ID:
- RPEP-00312
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-00312APA
Wild, C T; Shugars, D C; Greenwell, T K; McDanal, C B; Matthews, T J. (1994). Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.. Proceedings of the National Academy of Sciences of the United States of America, 91(21), 9770-4.
MLA
Wild, C T, et al. "Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.." Proceedings of the National Academy of Sciences of the United States of America, 1994.
RethinkPeptides
RethinkPeptides Research Database. "Peptides corresponding to a predictive alpha-helical domain ..." RPEP-00312. Retrieved from https://rethinkpeptides.com/research/wild-1994-peptides-corresponding-to-a
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.